Stenotic Crohn’s disease is a subtype of Crohn’s disease characterized by the formation of strictures or narrowing in the intestines, primarily driven by chronic inflammation and subsequent fibrosis. This chronic inflammation damages the intestinal wall, leading to the deposition of scar tissue (fibrosis), which narrows the intestinal passage and can cause bowel obstruction. As a result, patients often experience symptoms such as abdominal pain, bloating, and difficulty passing stool, significantly impacting their quality of life.

$10 Billion

IBD Market Opportunity³

1. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population NIH external link. Digestive Diseases and Sciences. 2013;58(2):519–525. doi:10.1007/s10620-012-2371-5
2. Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV. Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010 NIH external link. Clinical Gastroenterology and Hepatology. 2017;15(6):857–863. doi:10.1016/j.cgh.2016.10.039
3. Back Bay analysis and prior work, Gastroenterology. 2019 Feb;156(3):748-764, MK Willian et al., J Patient Rep Outcomes. 2018 Dec; 2:22, Aliment Pharmacol Ther. 2010 Apr;31(7):693-707, Frontline Gastroenterol. 2021; 12(3): 207–213, Ther Clin Risk Manag. 2007 Oct; 3(5): 893–903